{"entity":{"type":"insider","cik":"0001604646","url":"/insider/0001604646","json_url":"/insider/0001604646.json","name":"Cole Hugh M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":9,"first":"2016-06-29","last":"2023-01-11","span_basis":"filed_date"},"name_variants":[{"name":"Cole Hugh M","source":"filing","n_filings":9,"first_seen":"2016-06-29","last_seen":"2023-01-11"}],"transactions":[{"id":8269077,"accession":"0001640455-23-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-23-000008","line_url":"/filing/0001640455-23-000008#line-2","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9182.0,"shares_display":"9,182","price_per_share":1.12,"price_display":"1.12","price_state":"stated","total_value":10283.84,"total_display":"10,283.84","total_whole":"10,284","shares_owned_after":110082.0,"shares_owned_after_display":"110,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider"},{"id":8269071,"accession":"0001640455-23-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-23-000008","line_url":"/filing/0001640455-23-000008#line-1","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7452.0,"shares_display":"7,452","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":8197.2,"total_display":"8,197.20","total_whole":"8,197","shares_owned_after":119264.0,"shares_owned_after_display":"119,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6688403,"accession":"0001640455-22-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-22-000008","line_url":"/filing/0001640455-22-000008#line-2","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6205.0,"shares_display":"6,205","price_per_share":6.65,"price_display":"6.65","price_state":"stated","total_value":41263.25,"total_display":"41,263.25","total_whole":"41,263","shares_owned_after":64216.0,"shares_owned_after_display":"64,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-11","scope":"insider"},{"id":6688401,"accession":"0001640455-22-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-22-000008","line_url":"/filing/0001640455-22-000008#line-1","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3468.0,"shares_display":"3,468","price_per_share":7.3,"price_display":"7.30","price_state":"stated","total_value":25316.4,"total_display":"25,316.40","total_whole":"25,316","shares_owned_after":70421.0,"shares_owned_after_display":"70,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"},{"id":4647066,"accession":"0001640455-21-000021","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001640455-21-000021","line_url":"/filing/0001640455-21-000021#line-3","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":11.95,"price_display":"11.95","price_state":"stated","total_value":215100.0,"total_display":"215,100.00","total_whole":"215,100","shares_owned_after":47189.0,"shares_owned_after_display":"47,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-22","filed_date":"2021-01-25","scope":"insider"},{"id":4578840,"accession":"0001640455-21-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-21-000007","line_url":"/filing/0001640455-21-000007#line-2","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3340.0,"shares_display":"3,340","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":23380.0,"total_display":"23,380.00","total_whole":"23,380","shares_owned_after":55189.0,"shares_owned_after_display":"55,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-11","scope":"insider"},{"id":4578836,"accession":"0001640455-21-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-21-000007","line_url":"/filing/0001640455-21-000007#line-1","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2879.0,"shares_display":"2,879","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":19462.04,"total_display":"19,462.04","total_whole":"19,462","shares_owned_after":58529.0,"shares_owned_after_display":"58,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-11","scope":"insider"},{"id":2933297,"accession":"0001640455-20-000107","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001640455-20-000107","line_url":"/filing/0001640455-20-000107#line-3","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":744.0,"shares_display":"744","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":3504.24,"total_display":"3,504.24","total_whole":"3,504","shares_owned_after":61408.0,"shares_owned_after_display":"61,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-18","scope":"insider"},{"id":2933291,"accession":"0001640455-20-000107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-20-000107","line_url":"/filing/0001640455-20-000107#line-2","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":454.0,"shares_display":"454","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":2206.44,"total_display":"2,206.44","total_whole":"2,206","shares_owned_after":62152.0,"shares_owned_after_display":"62,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":2933284,"accession":"0001640455-20-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-20-000107","line_url":"/filing/0001640455-20-000107#line-1","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":984.0,"shares_display":"984","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":4565.76,"total_display":"4,565.76","total_whole":"4,566","shares_owned_after":62606.0,"shares_owned_after_display":"62,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-18","scope":"insider"},{"id":2828690,"accession":"0001640455-20-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-20-000003","line_url":"/filing/0001640455-20-000003#line-1","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2624.0,"shares_display":"2,624","price_per_share":7.78,"price_display":"7.78","price_state":"stated","total_value":20414.72,"total_display":"20,414.72","total_whole":"20,415","shares_owned_after":33590.0,"shares_owned_after_display":"33,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-10","scope":"insider"},{"id":7899420,"accession":"0001640455-19-000077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001640455-19-000077","line_url":"/filing/0001640455-19-000077#line-3","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1018.0,"shares_display":"1,018","price_per_share":3.92,"price_display":"3.92","price_state":"stated","total_value":3990.56,"total_display":"3,990.56","total_whole":"3,991","shares_owned_after":36214.0,"shares_owned_after_display":"36,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-16","scope":"insider"},{"id":7899418,"accession":"0001640455-19-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-19-000077","line_url":"/filing/0001640455-19-000077#line-2","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":648.0,"shares_display":"648","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2592.0,"total_display":"2,592.00","total_whole":"2,592","shares_owned_after":37232.0,"shares_owned_after_display":"37,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider"},{"id":7899415,"accession":"0001640455-19-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-19-000077","line_url":"/filing/0001640455-19-000077#line-1","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":670.0,"shares_display":"670","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":2747.0,"total_display":"2,747.00","total_whole":"2,747","shares_owned_after":37880.0,"shares_owned_after_display":"37,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-16","scope":"insider"},{"id":6643501,"accession":"0001640455-18-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-18-000072","line_url":"/filing/0001640455-18-000072#line-1","is_derivative":false,"issuer_cik":"0001604646","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001604646","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":7.84,"price_display":"7.84","price_state":"stated","total_value":14896.0,"total_display":"14,896.00","total_whole":"14,896","shares_owned_after":1900.0,"shares_owned_after_display":"1,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-18","scope":"insider"},{"id":2067695,"accession":"0000884731-16-000081","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000884731-16-000081","line_url":"/filing/0000884731-16-000081#line-3","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001604646","owner_name":"Cole Hugh M","owner_display_name":"Cole Hugh M","owner_url":"/insider/0001604646","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6012.0,"shares_display":"6,012","price_per_share":7.05,"price_display":"7.05","price_state":"stated","total_value":42384.6,"total_display":"42,384.60","total_whole":"42,385","shares_owned_after":29916.0,"shares_owned_after_display":"29,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-28","filed_date":"2016-06-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640455","name":"Jounce Therapeutics, Inc.","url":"/issuer/0001640455","role":"Officer (Chief Operating Officer)","n_filings":8,"first_seen":"2018-06-18","last_seen":"2023-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0000884731","name":"ARIAD PHARMACEUTICALS INC","url":"/issuer/0000884731","role":"Officer (SVP, Chief Business Officer)","n_filings":1,"first_seen":"2016-06-29","last_seen":"2016-06-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604646","retrieved_at":"2026-08-23T06:47:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}